Jun 30, 2026 09:01AM

Jun 30, 2026 09:00AM

Feb 10, 2026 04:10PM

Nov 4, 2025 08:56AM

Oct 7, 2025 08:32AM

Oct 7, 2025 08:30AM

Feb 5, 2025 04:05PM Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2025 Financial Results

Nov 11, 2024 04:31PM

Nov 11, 2024 04:20PM

Nov 7, 2024 08:45AM

Sep 17, 2024 08:54AM

Sep 17, 2024 08:30AM

Mar 27, 2024 07:30AM

Oct 15, 2021 09:22AM Pre-Open Stock Movers 10/15: (SNOA) (ME) (LVTX) Higher; (DCT) (SPCE) (CRSR) Lower (more...)

Mar 31, 2021 04:12PM

Mar 31, 2021 04:10PM

Aug 8, 2018 04:05PM

Jun 13, 2018 04:05PM

Apr 5, 2018 07:07AM

Apr 5, 2018 07:05AM

Feb 7, 2018 04:05PM Sonoma Pharmaceuticals Reports Record Total Revenue of $4.8 million for Third Quarter FY 2018 with Year over Year Product Revenue Growth of 46%

Dec 5, 2017 07:10AM

Dec 5, 2017 07:05AM

Nov 16, 2017 07:47AM

Nov 16, 2017 07:45AM

Nov 9, 2017 04:05PM

Oct 3, 2017 06:41AM

Oct 3, 2017 04:05AM Sonoma Pharmaceuticals Announces U.S. Commercialization of Loyon® for Relief of Scaling, Burning and Itching Associated with Various Dermatoses Including Seborrhea and Seborrheic Dermatitis

Sep 14, 2017 05:43AM

Sep 14, 2017 04:05AM

Aug 8, 2017 04:05PM

Jun 5, 2017 04:05PM

Mar 29, 2017 08:55AM

Mar 29, 2017 05:47AM

Mar 29, 2017 04:05AM Sonoma Pharmaceuticals Receives U.S. FDA Clearance of Loyon® Skin Descaler for Relief of Scaling Associated with Various Dermatoses

Mar 16, 2017 04:05AM

Feb 28, 2017 04:05AM

324,764 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All